Limitations in the Use of Cystatin C as a Predictor of Major Adverse Cardiovascular Events: Consideration of Non-Renal Factors [Letter]

Int J Gen Med. 2023 Jun 17:16:2555-2556. doi: 10.2147/IJGM.S425358. eCollection 2023.
No abstract available